Welcome to KenricoCare. KenricoCare has been provided since 1985 and is supported by Kenrico medical doctors. We are priviledged to answer any of your health-related questions and will help you with our suggestions based on our expertise. Please refer to the posting guidelines below before you post your question.

  • Next topic: question - Started by Sara July 28, 2007 at 09:04:19 PM
  • Previous topic: clear pads - Started by Sara July 25, 2007 at 11:05:11 AM

Re(1): Fibromyalgia, bone spurs

Posted on July 28, 2007 at 03:27:58 AM by KenricoCare
Hi there,

The gold edition pads (TRMX-2) is the chosen pad to treat fibromyalgia and bone spurs. For high blood pressure, we higly recommend the red edition pads (EXA-2).

Skin tags can be considered as tumor in a sense that it is a growth. However, it is a benign condition (harmless and not a malignant) and never turn into cancer. Weight gain and aging is atrributed to the development of skin tags. To start losing weight, we highly recommend the TG-1 (advanced grapefruit pads), SS1L (grapefruit pads) and CC pads (green tea pads).

All the best,
Kenrico Support

Thread overview

  • Fibromyalgia, bone spurs - By Julie Millsap July 26, 2007 at 10:32:50 AM
    • Re(1): Fibromyalgia, bone spurs - By KenricoCare July 28, 2007 at 03:27:58 AM

Posting a reply disabled

You can't reply to this message because this message is too old.

  • Next topic: question - Started by Sara July 28, 2007 at 09:04:19 PM
  • Previous topic: clear pads - Started by Sara July 25, 2007 at 11:05:11 AM
KenricoCare is developed to meet the requirement of CE & ISO 9001:2018 Quality Management System. Visit the Distributors page for Distributorship information. KenricoCare is for medical support and consultation only, meaning that we do not allow posting of brand names, website links, or inflammatory post. A VALID email address is required to post. We reserve the right to edit or delete posts that do not follow our posting guidelines. Further posting of deleted posts will cause you banned permanently.